Milrinone Lactate
NDC Package 62778-059-02
Package Information
Milrinone Lactate is a medication used for the short-term treatment of heart failure. Marketed by Hikma Farmaceutica, this product is identified by NDC 62778-059 and is authorized under FDA application ANDA077966.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62778 - Hikma Farmaceutica
- 62778-059 - Milrinone Lactate
- 62778-059-02 - 10 VIAL in 1 BOX / 10 mL in 1 VIAL (62778-059-01)
- 62778-059 - Milrinone Lactate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (62778-059). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62778-059-02 identifies a specific commercial package of 10 vial in 1 box / 10 ml in 1 vial (62778-059-01) of Milrinone Lactate, labeled by Hikma Farmaceutica. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hikma Farmaceutica on December 03, 2010. The current certification is valid through December 03, 2010.
What are the primary indications for this medication?
This medication is used for the short-term treatment of heart failure. It works by making your heart beat stronger and by relaxing certain blood vessels so that the amount of blood that is pumped from the heart is increased. This effect may help with symptoms of heart failure (such as shortness of breath, tiredness).
How is this Hikma Farmaceutica product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62778005902. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.